NCR2 and glioblastoma: Significant negative correlation between the expression of NT5E and individual genes NCR1 and NCR2, which encode the activating receptors NKp46 and NKp44, respectively, suggests that CD73 activity in GBM might impair the activation of NK cells by downregulating individual receptor-specific functions.